Selective avoidance of lymphatic irradiation in the conservative management of breast cancer.
Identifieur interne : 00AA92 ( Ncbi/Checkpoint ); précédent : 00AA91; suivant : 00AA93Selective avoidance of lymphatic irradiation in the conservative management of breast cancer.
Auteurs : J R YarnoldSource :
- Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [ 0167-8140 ] ; 1984.
Descripteurs français
- KwdFr :
- Articulation glénohumérale (physiologie), Femelle, Humains, Lymphoedème (étiologie), Mastectomie (effets indésirables), Mouvement, Noeuds lymphatiques (effets des radiations), Oedème (étiologie), Radiothérapie (effets indésirables), Récidive tumorale locale, Stade de la tumeur, Tumeurs du sein (mortalité), Tumeurs du sein (radiothérapie).
- MESH :
- effets des radiations : Noeuds lymphatiques.
- effets indésirables : Mastectomie, Radiothérapie.
- mortalité : Tumeurs du sein.
- physiologie : Articulation glénohumérale.
- radiothérapie : Tumeurs du sein.
- étiologie : Lymphoedème, Oedème.
- Femelle, Humains, Mouvement, Récidive tumorale locale, Stade de la tumeur.
English descriptors
- KwdEn :
- MESH :
- adverse effects : Mastectomy, Radiotherapy.
- etiology : Edema, Lymphedema.
- mortality : Breast Neoplasms.
- physiology : Shoulder Joint.
- radiation effects : Lymph Nodes.
- radiotherapy : Breast Neoplasms.
- Female, Humans, Movement, Neoplasm Recurrence, Local, Neoplasm Staging.
Abstract
High-dose lymphatic irradiation is a contributory factor to the morbidity of treatment after local excision and high-dose radiotherapy for early stage breast cancer and may detract significantly from the cosmetic result. The apparent inability of lymphatic irradiation to influence the survival of patients with early stage breast cancer supports an argument for the selective avoidance of regional radiotherapy in a proportion of patients. Based on a review of the effects of lymphatic radiotherapy on lymphatic control, complications, cosmesis, survival and the effects of withholding lymphatic irradiation, recommendations are made for the selective treatment of patients at high risk of regional recurrence. In patients submitted to full axillary dissection, node negative patients require no lymphatic irradiation. After full axillary dissection radiotherapy is confined to the supraclavicular fossa in patients with heavy axillary involvement. A policy for patients having limited axillary dissection is discussed which identifies approximately 50% of patients as eligible for careful watch policy following local excision and high-dose radiotherapy to the primary disease.
PubMed: 6505287
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 006928
- to stream PubMed, to step Curation: 006928
- to stream PubMed, to step Checkpoint: 006928
- to stream Ncbi, to step Merge: 00AA92
- to stream Ncbi, to step Curation: 00AA92
Links to Exploration step
pubmed:6505287Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Selective avoidance of lymphatic irradiation in the conservative management of breast cancer.</title>
<author><name sortKey="Yarnold, J R" sort="Yarnold, J R" uniqKey="Yarnold J" first="J R" last="Yarnold">J R Yarnold</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1984">1984</date>
<idno type="RBID">pubmed:6505287</idno>
<idno type="pmid">6505287</idno>
<idno type="wicri:Area/PubMed/Corpus">006928</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">006928</idno>
<idno type="wicri:Area/PubMed/Curation">006928</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">006928</idno>
<idno type="wicri:Area/PubMed/Checkpoint">006928</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">006928</idno>
<idno type="wicri:Area/Ncbi/Merge">00AA92</idno>
<idno type="wicri:Area/Ncbi/Curation">00AA92</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">00AA92</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Selective avoidance of lymphatic irradiation in the conservative management of breast cancer.</title>
<author><name sortKey="Yarnold, J R" sort="Yarnold, J R" uniqKey="Yarnold J" first="J R" last="Yarnold">J R Yarnold</name>
</author>
</analytic>
<series><title level="j">Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</title>
<idno type="ISSN">0167-8140</idno>
<imprint><date when="1984" type="published">1984</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Neoplasms (mortality)</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Edema (etiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Lymph Nodes (radiation effects)</term>
<term>Lymphedema (etiology)</term>
<term>Mastectomy (adverse effects)</term>
<term>Movement</term>
<term>Neoplasm Recurrence, Local</term>
<term>Neoplasm Staging</term>
<term>Radiotherapy (adverse effects)</term>
<term>Shoulder Joint (physiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Articulation glénohumérale (physiologie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème (étiologie)</term>
<term>Mastectomie (effets indésirables)</term>
<term>Mouvement</term>
<term>Noeuds lymphatiques (effets des radiations)</term>
<term>Oedème (étiologie)</term>
<term>Radiothérapie (effets indésirables)</term>
<term>Récidive tumorale locale</term>
<term>Stade de la tumeur</term>
<term>Tumeurs du sein (mortalité)</term>
<term>Tumeurs du sein (radiothérapie)</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Mastectomy</term>
<term>Radiotherapy</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des radiations" xml:lang="fr"><term>Noeuds lymphatiques</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Mastectomie</term>
<term>Radiothérapie</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Edema</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Articulation glénohumérale</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Shoulder Joint</term>
</keywords>
<keywords scheme="MESH" qualifier="radiation effects" xml:lang="en"><term>Lymph Nodes</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term>
<term>Oedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Movement</term>
<term>Neoplasm Recurrence, Local</term>
<term>Neoplasm Staging</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Femelle</term>
<term>Humains</term>
<term>Mouvement</term>
<term>Récidive tumorale locale</term>
<term>Stade de la tumeur</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">High-dose lymphatic irradiation is a contributory factor to the morbidity of treatment after local excision and high-dose radiotherapy for early stage breast cancer and may detract significantly from the cosmetic result. The apparent inability of lymphatic irradiation to influence the survival of patients with early stage breast cancer supports an argument for the selective avoidance of regional radiotherapy in a proportion of patients. Based on a review of the effects of lymphatic radiotherapy on lymphatic control, complications, cosmesis, survival and the effects of withholding lymphatic irradiation, recommendations are made for the selective treatment of patients at high risk of regional recurrence. In patients submitted to full axillary dissection, node negative patients require no lymphatic irradiation. After full axillary dissection radiotherapy is confined to the supraclavicular fossa in patients with heavy axillary involvement. A policy for patients having limited axillary dissection is discussed which identifies approximately 50% of patients as eligible for careful watch policy following local excision and high-dose radiotherapy to the primary disease.</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Yarnold, J R" sort="Yarnold, J R" uniqKey="Yarnold J" first="J R" last="Yarnold">J R Yarnold</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00AA92 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 00AA92 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= pubmed:6505287 |texte= Selective avoidance of lymphatic irradiation in the conservative management of breast cancer. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:6505287" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |